SCHEMBL8801293

SCHEMBL8801293

CSc1nc2c(Cc3cccc(Cl)c3)c[nH]c2c(=O)[nH]1

nearest known ligand 0.71

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
PNP P00491 7/20 0.71
PDE5A O76074 1/20 0.43
PDE9A O76083 1/20 0.43
PDE1A P54750 1/20 0.43
PDE1B Q01064 1/20 0.43
PDE1C Q14123 1/20 0.43
GFER P55789 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9221096 0.86 PNP (0.67) PNP
SCHEMBL6345393 0.83 PNP (1.00) PNP
SCHEMBL9220277 0.81 PNP (0.59) PNP
SCHEMBL9224582 0.81 PNP (0.70) PNPGFER
SCHEMBL9220598 0.77 PNP (0.69) PNP
SCHEMBL10650946 0.76 PLA2G7 (0.57) PNP
SCHEMBL6344896 0.71 PNP (0.75) PNP
SCHEMBL9166149 0.70 DPYD (0.60)
SCHEMBL17139842 0.70 PNP (0.71) PNP
SCHEMBL6340397 0.69 PNP (0.75) PNP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0460116-B1 9-SUBSTITUTED-8-UNSUBSTITUTED-9-DEAZAGUANINES BIOCRYST PHARM INC (US) 1997-08-27 EP disclosed
US-5565463-A PURINE NUCLEOSIDE PHOSPHORYLASE INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 1996-10-15 US disclosed
EP-0460116-A4 9-SUBSTITUTED-8-UNSUBSTITUTED-9-DEAZAGUANINES 1992-05-13 EP disclosed
EP-0460116-A1 9-SUBSTITUTED-8-UNSUBSTITUTED-9-DEAZAGUANINES. BIOCRYST (US) 1991-12-11 EP disclosed
WO-1990010631-A1 9-SUBSTITUTED-8-UNSUBSTITUTED-9-DEAZAGUANINES BIOCRYST (US) 1990-09-20 WO disclosed